Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 212
Filtrer
1.
Thromb Res ; 196: 186-192, 2020 12.
Article de Anglais | MEDLINE | ID: mdl-32891904

RÉSUMÉ

BACKGROUND: COVID-19 is a novel viral disease. Severe courses may present as ARDS. Several publications report a high incidence of coagulation abnormalities in these patients. We aimed to compare coagulation and inflammation parameters in patients with ARDS due to SARS-CoV-2 infection versus patients with ARDS due to other causes. METHODS: This retrospective study included intubated patients admitted with the diagnosis of ARDS to the ICU at Munich university hospital. 22 patients had confirmed SARS-CoV2-infection (COVID-19 group), 14 patients had bacterial or other viral pneumonia (control group). Demographic, clinical parameters and laboratory tests including coagulation parameters and thromboelastometry were analysed. RESULTS: No differences were found in gender ratios, BMI, Horovitz quotients and haemoglobin values. The median SOFA score, serum lactate levels, renal function parameters (creatinine, urea) and all inflammation markers (IL-6, PCT, CRP) were lower in the COVID-19 group (all: p < 0.05). INR (p < 0.001) and antithrombin (p < 0.001) were higher in COVID-19 patients. D-dimer levels (p = 0.004) and consecutively the DIC score (p = 0.003) were lower in this group. In ExTEM®, Time-to-Twenty (TT20) was shorter in the COVID-19 group (p = 0.047), these patients also had higher FibTEM® MCF (p = 0.005). Further, these patients presented with elevated antigen and activity levels of von-Willebrand-Factor (VWF). CONCLUSION: COVID-19 patients presented with higher coagulatory potential (shortened global clotting tests, increased viscoelastic and VWF parameters), while DIC scores were lower. An intensified anticoagulation regimen based on an individual risk assessment is advisable to avoid thromboembolic complications.


Sujet(s)
Coagulation sanguine , COVID-19/complications , Coagulation intravasculaire disséminée/étiologie , /complications , SARS-CoV-2 , Maladie aigüe , Adulte , Sujet âgé , COVID-19/sang , Femelle , Humains , Mâle , Adulte d'âge moyen , /sang , Études rétrospectives
3.
Chirurg ; 79(3): 241-8, 2008 Mar.
Article de Allemand | MEDLINE | ID: mdl-17717640

RÉSUMÉ

BACKGROUND: The significance of pancreatic resection for pancreatic metastatic lesions has not yet been sufficiently investigated. A retrospective analysis of patients undergoing pancreatic resections for pancreatic metastases was conducted. MATERIAL AND METHODS: Twenty patients were resected due to metastatic lesions to the pancreas. Histopathological findings were: renal cell carcinoma (n=9), colon carcinoma (n=1), malignant schwannoma (n=2), leiomyosarcoma (n=2), teratocarcinoma (n=1), adenocarcinoma of the oesophagus (n=1), gallbladder carcinoma (n=1), malignant melanoma (n=1), gastrointestinal stromal tumor (n=1), and spindle cell tumor (n=1). Operative procedures were standard pancreaticoduodenectomy (n=6), pylorus-preserving pancreaticoduodenectomy (n=6), and distal pancreatectomy (n=8). RESULT: The overall 5-year survival rate was 61%, for patients with renal cell carcinoma 100%. CONCLUSION: Pancreatic metastasectomy is a reasonable therapeutic option in suited patients. Patients with pancreatic metastases of renal cell carcinoma achieved excellent prognoses after radical resection.


Sujet(s)
Pancréatectomie , Tumeurs du pancréas/secondaire , Tumeurs du pancréas/chirurgie , Sujet âgé , Traitement médicamenteux adjuvant , Association thérapeutique , Femelle , Études de suivi , Humains , Lymphadénectomie , Mâle , Adulte d'âge moyen , Soins palliatifs , Tumeurs du pancréas/diagnostic , Tumeurs du pancréas/mortalité , Taux de survie
4.
Acta Radiol ; 49(7): 744-6, 2008 Sep.
Article de Anglais | MEDLINE | ID: mdl-19143059

RÉSUMÉ

Sclerosing mesenteritis is a rare inflammatory disease of the bowel mesentery of unknown etiology, which can be mistaken for malignancy. We report a case of a 60-year-old male patient with sclerosing mesenteritis as a rare cause of upper abdominal pain and digestive disorders, and present the corresponding magnetic resonance imaging (MRI) findings indicative of the underlying disease.


Sujet(s)
Douleur abdominale/étiologie , Maladies de l'appareil digestif/étiologie , Imagerie par résonance magnétique/méthodes , Panniculite péritonéale/complications , Panniculite péritonéale/diagnostic , Produits de contraste , Diagnostic différentiel , Acide gadopentétique , Humains , Mâle , Adulte d'âge moyen
5.
Acta Radiol ; 48(8): 821-30, 2007 Oct.
Article de Anglais | MEDLINE | ID: mdl-17924212

RÉSUMÉ

BACKGROUND: Management of patients after locally ablative treatment of liver metastases requires exact information about local control and systemic disease status. To fulfill these requirements, whole-body imaging using positron emission tomography with (18)F-fluorodeoxyglucose (FDG-PET) is a promising alternative to morphologic imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI). PURPOSE: To evaluate FDG-PET for the assessment of local control and systemic disease in patients with clinical suspicion of tumor progression after laser-induced thermotherapy (LITT) of colorectal liver metastases. MATERIAL AND METHODS: In 21 patients with suspicion of progressive disease after LITT, whole-body FDG-PET was performed. The presence of viable tumor within treated lesions, new liver metastases, and extrahepatic disease was evaluated visually and semiquantitatively (maximal standard uptake value [SUV(max)], tumor-to-normal ratio [T/N]). The standard of reference was histopathology (n = 25 lesions) and/or clinical follow-up (>12 months) including contrast-enhanced MRI of the liver. RESULTS: Among 54 metastases treated with LITT, 29 had residual tumor. Receiver operating characteristic (ROC) analysis of SUV(max) (area under the curve (AUC) 0.990) and T/N (AUC 0.968) showed a significant discrimination level of negative or positive lesion status with an equal accuracy of 94% (51/54). The overall accuracy of visual FDG-PET was 96% (52/54), with one false-negative lesion among six examined within 3 days after LITT, and one false-positive lesion examined 54 days after LITT. In the detection of new intra- and extrahepatic lesions, FDG-PET resulted in correct alteration of treatment strategy in 43% of patients (P = 0.007). CONCLUSION: FDG-PET is a promising tool for the assessment of local control and whole-body restaging in patients with clinical suspicion of tumor progression after locally ablative treatment of colorectal liver metastases with LITT.


Sujet(s)
Tumeurs colorectales/anatomopathologie , Fluorodésoxyglucose F18 , Tumeurs du foie/imagerie diagnostique , Tumeurs du foie/secondaire , Maladie résiduelle/imagerie diagnostique , Tomographie par émission de positons/méthodes , Adulte , Sujet âgé , Ablation par cathéter , Erreurs de diagnostic , Évolution de la maladie , Femelle , Études de suivi , Humains , Hyperthermie provoquée/méthodes , Thérapie laser/méthodes , Tumeurs du foie/chirurgie , Mâle , Adulte d'âge moyen , Courbe ROC , Sensibilité et spécificité
8.
Chirurg ; 78(8): 748-56, 2007 Aug.
Article de Allemand | MEDLINE | ID: mdl-17646947

RÉSUMÉ

Since the introduction of diagnosis-related groups (DRGs) many surgical departments report inappropriate reimbursement for complex cases and a shift in costly cases. To evaluate this situation, the German Society for Visceral Surgery inaugurated the present cost calculation project. In three university hospitals for 50 cases each, we depicted possible cost separators and utilized the complete cost calculation data (so-called Paragraph 21 data set) to test these separators. We identified "admission from another hospital", "severe surgically relevant concomitant disease", and "reoperation during the same hospital admission". The last was considered the economically most significant and medically most valid factor and was submitted as a possible modification to the german DRG system. The proposed cost separator "reoperation during the same hospital admission" was introduced into the DRG system after validation and leads to better allocation of reimbursements to complex and costly cases.


Sujet(s)
Groupes homogènes de malades/économie , Programmes nationaux de santé/économie , Procédures de chirurgie opératoire/économie , Technologie coûteuse/économie , Viscères/chirurgie , Comorbidité , Coûts et analyse des coûts , Allemagne , Coûts hospitaliers/statistiques et données numériques , Humains , Durée du séjour/économie , Transfert de patient/économie , Mécanismes de remboursement/économie , Réintervention/économie
9.
Br J Cancer ; 97(4): 523-30, 2007 Aug 20.
Article de Anglais | MEDLINE | ID: mdl-17622249

RÉSUMÉ

Activation of nuclear factor-kappaB (NF-kappaB) signaling was observed in pancreatic adenocarcinoma cell lines and tumours. However, information on the expression of RelA/p65, the major transcription activating NF-kappaB subunit, in these carcinomas and possible correlations thereof with NF-kappaB activation and patient survival is not available. To provide this missing translational link, we analysed expression of RelA/p65 in 82 pancreatic adenocarcinomas by immunohistochemistry. Moreover, we measured activation of the NF-kappaB pathway in 11 tumours by quantitative PCR for NF-kappaB target genes. We observed strong cytoplasmic or nuclear expression of RelA/p65 in 42 and 37 carcinomas, respectively. High cytoplasmic and nuclear expression of RelA/p65 had negative prognostic impact with 2-year survival rates for patients without cytoplasmic or nuclear RelA/p65 positivity of 41 and 40% and rates for patients with strong cytoplasmic or nuclear RelA/p65 expression of 22 and 20%, respectively. High RelA/p65 expression was correlated to increased expression of NF-kappaB target genes. The observation that high expression of RelA/p65 is correlated to an activation of the NF-kappaB pathway and indicates poor patient survival identifies a patient subgroup that might particularly benefit from NF-kappaB-inhibiting agents in the treatment of pancreatic cancer. Based on our findings, this subgroup could be identified by applying simple immunohistochemical techniques.


Sujet(s)
Adénocarcinome/diagnostic , Adénocarcinome/génétique , Facteur de transcription NF-kappa B/métabolisme , Tumeurs du pancréas/diagnostic , Tumeurs du pancréas/génétique , Facteur de transcription RelA/génétique , Adénocarcinome/métabolisme , Adénocarcinome/mortalité , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Marqueurs biologiques tumoraux/génétique , Études de suivi , Régulation de l'expression des gènes tumoraux , Humains , Adulte d'âge moyen , Tumeurs du pancréas/métabolisme , Tumeurs du pancréas/mortalité , Pronostic , Transduction du signal , Analyse de survie , Facteur de transcription RelA/métabolisme
10.
Zentralbl Chir ; 132(2): 112-7, 2007 Apr.
Article de Allemand | MEDLINE | ID: mdl-17516316

RÉSUMÉ

BACKGROUND: Acute appendicitis is the most common cause of an acute abdomen in pregnancy. However, due to the potential fetal risk associated with the CO2-pneumoperitoneum and various operative technical reasons there is still controversy about the role of laparoscopic appendectomy in pregnant women. PATIENTS AND METHODS: Between January 2000 and November 2005, 283 women between 17 and 45 years with suspected appendicitis underwent laparoscopic appendectomy at our institution. Fifteen of these patients (5.3 %) were pregnant at the time of surgery (mean age, 28 years; range, 18-40 years; mean gestational age, 21.9 weeks; range, 14-34 weeks). Perioperative obstetric monitoring included fetal ultrasound, including Doppler sonography and cardiotocography. Clinical data were collected prospectively. Complete follow-up data were available in 14 patients. RESULTS: All 15 patients underwent successful laparoscopic appendectomy. Mean operation time was 53 minutes (range, 30-100 minutes). The histologic appendicitis / appendectomy ratio was 73 %. One patient showed a postoperative pyelonephritis, another a cystitis. Average length of hospital stay was 5.5 days (range, 3-10 days). All fourteen pregnancies with complete follow-up resulted in delivery of healthy infants. The mean gestational age at delivery was 39.6 weeks (range, 35-42 weeks). Two patients (14.3 %) had a preterm delivery at 35 weeks with uncomplicated outcome. One patient underwent caesarean section at 41 weeks after chorioamnionitis. CONCLUSIONS: Laparoscopic appendectomy is a safe and effective method to treat acute appendicitis in pregnant women regardless of the trimester. For the best outcome the operation should be performed in a center where surgeons, perinatologist, obstetricians and anesthesiologists work together as a part of an interdisciplinary team.


Sujet(s)
Appendicectomie , Appendicite/chirurgie , Laparoscopie , Complications de la grossesse/chirurgie , Abdomen aigu/étiologie , Abdomen aigu/chirurgie , Adolescent , Adulte , Diagnostic différentiel , Femelle , Études de suivi , Allemagne , Humains , Nouveau-né , Durée du séjour , Adulte d'âge moyen , Travail obstétrical prématuré/étiologie , Pneumopéritoine artificiel , Complications postopératoires/étiologie , Grossesse
11.
Langenbecks Arch Surg ; 392(6): 657-62, 2007 Nov.
Article de Anglais | MEDLINE | ID: mdl-17443341

RÉSUMÉ

BACKGROUND: Adult living donor liver transplantation (LDLT) has become a routine treatment option for patients waiting for liver transplantation. In European and North American countries, LDLT for adult recipients is mainly performed with right lobe grafts. Indications, when compared to deceased donor liver transplantation, are controversial. MATERIALS AND METHODS: In our institution, patients suffering from hepatocellular carcinoma in cirrhosis, non-resectable hilar cholangiocarcinoma, viral hepatitis associated cirrhosis, as well as cholestatic liver and biliary disease are considered good candidates for LDLT. RESULTS: In this overview, donor evaluation, graft selection, and the donor operation with special regard to operative techniques and strategies are discussed. For visualization, a 5-min video sequence of the standard donor operation as performed in our institution is attached. CONCLUSION: Given the ongoing shortage of donor organs, adult LDLT has become a routine treatment option for patients waiting for liver transplantation. The associated inevitable risk for the healthy donor, however, remains ethically controversial.


Sujet(s)
Défaillance hépatique/chirurgie , Transplantation hépatique/méthodes , Donneur vivant , Adulte , Tumeurs des canaux biliaires/chirurgie , Conduits biliaires intrahépatiques , Carcinome hépatocellulaire/chirurgie , Cholangiocarcinome/chirurgie , Sélection de donneurs/méthodes , Hépatectomie/méthodes , Hépatites virales humaines/chirurgie , Humains , Cirrhose biliaire/chirurgie , Défaillance hépatique/étiologie , Tumeurs du foie/chirurgie , Pronostic , Prélèvement d'organes et de tissus/méthodes
12.
Acta Radiol ; 48(4): 379-87, 2007 May.
Article de Anglais | MEDLINE | ID: mdl-17453515

RÉSUMÉ

PURPOSE: To assess image quality and overall accuracy of 3-Tesla (3T)-sustained high-resolution magnetic resonance (MR) imaging for diagnostic preoperative workup in suspected rectal carcinoma. MATERIAL AND METHODS: Twenty-three patients with suspected rectal cancer underwent unenhanced and contrast-enhanced fat-suppressed pelvic high-resolution MR imaging using a four-channel phased-array pelvic coil at 3T. Image quality, tumor stage, distance from the anorectal margin, and sphincter-saving resectability were prospectively assessed by two blinded readers. The results were correlated with clinical, surgical, and histopathologic findings. RESULTS: In all 23 patients, MR images were of diagnostic quality, and malignancy was correctly identified in 21 patients. The accuracy for determining sphincter-saving resectability was 100% (19/19). T stage and N stage were correctly diagnosed in 95% and 91%, respectively. MRI allowed correct identification of tumor extension and its relation to surgically relevant pelvic structures including the anorectal margin and mesorectal fascia. Transverse T2-weighted fast spin-echo images compared superiorly to all other sequences for the diagnosis of mesorectal infiltration and lymph node involvement. Moreover, transverse fat-suppressed contrast-enhanced T1-weighted images were valuable for identifying tumor infiltration, while sagittal sections were useful for the detection of longitudinal tumor extension. CONCLUSION: MR imaging with phased-array receiver coils at 3T facilitated both visualization of different pathologic conditions of the rectum and accurate determination of tumor stage in rectal carcinomas. Thus, this noninvasive diagnostic approach appeared highly suitable for the assessment of patients with suspected rectal carcinoma.


Sujet(s)
Canal anal/chirurgie , Traitement d'image par ordinateur/méthodes , Imagerie par résonance magnétique/méthodes , Tumeurs du rectum/diagnostic , Adénocarcinome/diagnostic , Adénocarcinome/anatomopathologie , Adénocarcinome/chirurgie , Polypes adénomateux/diagnostic , Polypes adénomateux/anatomopathologie , Polypes adénomateux/chirurgie , Sujet âgé , Canal anal/anatomopathologie , Produits de contraste , Infections à cytomégalovirus/diagnostic , Fascia/anatomopathologie , Humains , Amélioration d'image/méthodes , Métastase lymphatique/diagnostic , Adulte d'âge moyen , Invasion tumorale , Stadification tumorale , Valeur prédictive des tests , Soins préopératoires , Rectite/diagnostic , Rectite/virologie , Études prospectives , Tumeurs du rectum/anatomopathologie , Tumeurs du rectum/chirurgie , Rectum/anatomopathologie , Sensibilité et spécificité
13.
Transplant Proc ; 39(2): 535-6, 2007 Mar.
Article de Anglais | MEDLINE | ID: mdl-17362775

RÉSUMÉ

In liver transplantation, "fast tracking" means postoperative extubation in the operating theater immediately after surgery. This procedure was performed in a series of 837 adult liver transplant recipients between January 1997 and April 2005, proving to be safe and feasible in almost 80% of patients without increasing the incidence of reintubation. This patient population experienced a significantly higher survival compared to patients who were extubated in the intensive care unit. Consequently, fast tracking should become the standard procedure after orthotopic liver transplantation. However, special attention is required for recipients with acute liver failure, retransplantation, Child C status, or complicated surgery in terms of increased transfusion of red blood cells. These patients do not participate in fast-tracking protocols, as demonstrated by a uni- and multivariate logistic regression analysis. Moreover, ROC analysis revealed that only intraoperative transfusion of

Sujet(s)
Transplantation hépatique/statistiques et données numériques , Humains , Transplantation hépatique/mortalité , Dossiers médicaux , Sélection de patients , Études rétrospectives , Analyse de survie , Facteurs temps , Listes d'attente
14.
Transplant Proc ; 39(2): 563-4, 2007 Mar.
Article de Anglais | MEDLINE | ID: mdl-17362782

RÉSUMÉ

Simultaneous pancreas kidney transplantation is currently the state of the art therapy for patients with type 1 diabetes mellitus and diabetic nephropathy. Up to 30% of patients loose the pancreas with a kidney graft that continues to function. Under those conditions, isolated pancreas retransplantation can be indicated. We compared the outcome of these patients with the outcome of patients undergoing primary pancreas after kidney transplantation. From 1998 to 2005, we performed 205 pancreas transplantations. Three patients were considered for isolated pancreas retransplantation; to date, two have received a new organ. One was retransplanted twice. In two cases, the reasons for the initial graft loss in the retransplantation group were pancreatitis with hemorrhagic bleeding and in the third case severe rejection. After retransplantation two of three patients lost their graft owing to bleeding and venous thrombosis. One of three organs was successfully transplanted and the patient does not require insulin. During the same time, three pancreas after kidney transplantations were performed; all are doing well und are free of insulin. The study despite the small number of cases shows a high complication rate after pancreas retransplantation. Nevertheless, pancreatic retransplantation should be considered in selected patients.


Sujet(s)
Transplantation rénale/effets indésirables , Transplantation pancréatique/effets indésirables , Réintervention/effets indésirables , Diabète de type 1/chirurgie , Néphropathies diabétiques/chirurgie , Rejet du greffon/épidémiologie , Humains , Défaillance rénale chronique/chirurgie , Complications postopératoires/classification , Complications postopératoires/épidémiologie , Études rétrospectives
15.
Acta Radiol ; 48(1): 20-6, 2007 Feb.
Article de Anglais | MEDLINE | ID: mdl-17325920

RÉSUMÉ

PURPOSE: To evaluate the accuracy of magnetic resonance angiography (MRA) for preoperative assessment of hepatic vascular anatomy in liver donors before living related liver transplantation. MATERIAL AND METHODS: A total of 55 consecutive living liver donors (mean age 42 years, range 18-68 years) underwent multiphase contrast-enhanced MRA of the hepatic vessels. Two readers categorized vessel visualization on a five-point scale and recorded vascular anatomy or variations thereof for the arterial, portal venous and venous systems. All 55 living liver donors subsequently underwent right hemihepatectomy for hemiliver donation, and preoperative MRA results were correlated with surgical findings. RESULTS: Overall vessel visualization assessment demonstrated good or very good ratings for the majority of patients. For hepatic arteries, the mean score was 4.4+/-0.8 (mean+/-standard deviation), and for the portal venous and venous systems it was 4.6+/-0.7 and 4.3+/-0.8, respectively. Among all 55 donors, 16 (29%) demonstrated accessory or replaced hepatic arteries, and seven (13%) and 20 (36%) donors had surgically relevant portal vein (trifurcation or early right posterolateral branching types) and hepatic vein variations, respectively. Correlation coefficients between MRA and surgery were 0.94, 1.00 and 0.91 for hepatic arteries, portal veins and hepatic veins, respectively. CONCLUSION: In the preoperative evaluation before living related liver donation, contrast-enhanced MR angiography was a highly accurate, noninvasive tool for visualizing the hepatic vasculature and variations thereof in liver donor candidates.


Sujet(s)
Transplantation hépatique/statistiques et données numériques , Foie/anatomie et histologie , Foie/vascularisation , Donneur vivant/statistiques et données numériques , Angiographie par résonance magnétique/méthodes , Soins préopératoires/méthodes , Adolescent , Adulte , Sujet âgé , Produits de contraste/administration et posologie , Acide gadopentétique/administration et posologie , Hépatectomie , Artère hépatique/anatomie et histologie , Artère hépatique/imagerie diagnostique , Veines hépatiques/anatomie et histologie , Veines hépatiques/imagerie diagnostique , Humains , Adulte d'âge moyen , Biais de l'observateur , Veine porte/anatomie et histologie , Veine porte/imagerie diagnostique , Amélioration d'image radiographique/méthodes , Reproductibilité des résultats
16.
Dis Esophagus ; 20(1): 19-23, 2007.
Article de Anglais | MEDLINE | ID: mdl-17227305

RÉSUMÉ

Postoperative chylothorax after injury of the thoracic duct during esophagectomy is a rare but severe complication which may lead to serious problems such as loss of fat and proteins, and immunodeficiency. Without treatment mortality can rise to over 50%. From 1988 to 2005, we treated 10 patients with postoperative chylothorax after 409 resections of the esophagus (2.4%). Of these 10 patients nine underwent transthoracic esophagectomy with gastric pull-up to enable an intrathoracic (n = 7) or cervical (n = 2) anastomosis and one patient received a transhiatal esophagectomy with gastric pull-up and cervical anastomosis. The average amount of postoperative chylus was 2205 mL (200-4500 mL) per day. After a median postoperative interval of 10 days, relaparotomy and transhiatal double ligation of the thoracic duct was performed in nine out of 10 patients. One patient could be managed conservatively. The average amount of chylus was reduced to 151 mL per day (90.5%). Seven patients had no complications, and three suffered from postoperative pneumonia. Two of the patients with pneumonia recovered, and one died. Discharge from hospital, after ligation of the thoracic duct, was possible after a median time of 18 days (11-52). Ligation of the thoracic duct via relaparotomy appeared to be a simple and safe method to treat postoperative chylothorax.


Sujet(s)
Chylothorax/chirurgie , Oesophagectomie , Complications peropératoires , Complications postopératoires/chirurgie , Conduit thoracique/traumatismes , Conduit thoracique/chirurgie , Sujet âgé , Femelle , Humains , Durée du séjour , Ligature , Mâle , Adulte d'âge moyen , Pneumopathie infectieuse/étiologie , Résultat thérapeutique
17.
Pancreatology ; 6(6): 512-9, 2006.
Article de Anglais | MEDLINE | ID: mdl-17106215

RÉSUMÉ

BACKGROUND: This study assessed the value of image fusion with (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) and magnetic resonance imaging (MRI) in patients suspected of having pancreatic cancer. METHODS: 32 patients (12 women, 20 men; age 24-79 years; mean 56.6 years) were included. All patients underwent whole-body FDG-PET examinations and contrast-enhanced MRI. Image fusion used a semiautomatic voxel-based algorithm. Separate reading, side-by-side analysis and evaluation of fused PET/MRI images were performed. Results were correlated to histopathology (n = 30), or clinical follow-up (n = 2). RESULTS: 15/32 patients had pancreas cancer and 17/32 patients benign disease. The sensitivity and specificity for cancer detection by FDG-PET were 93 and 41% for visual and 86 and 58% for semiquantitative analysis whereas MRI achieved 100 and 76% respectively. Topographical assignment of PET foci by image fusion was superior to side-by-side analysis in 11/39 (28%) foci (in 8/32 patients). However, a true impact on therapeutic strategy was observed only in 1/8 patients as the presence of multiple metastases, irresectable primaries or medical reasons for inoperability prevented a curative setting. CONCLUSION: Compared to side-by-side analysis, PET/MRI image fusion improves the anatomical assignment and interpretation of FDG foci. The therapeutic benefit for the patient however is limited in patients with multiple lesions or incurable primaries.


Sujet(s)
Adénocarcinome/imagerie diagnostique , Cystadénome/imagerie diagnostique , Traitement d'image par ordinateur/méthodes , Imagerie par résonance magnétique/méthodes , Tumeurs du pancréas/imagerie diagnostique , Tomographie par émission de positons , Adénocarcinome/secondaire , Adulte , Sujet âgé , Cystadénome/anatomopathologie , Femelle , Fluorodésoxyglucose F18 , Humains , Noeuds lymphatiques/anatomopathologie , Mâle , Adulte d'âge moyen , Tumeurs du pancréas/anatomopathologie , Valeur prédictive des tests , Radiopharmaceutiques , Études rétrospectives
18.
Dtsch Med Wochenschr ; 131(42): 2327-32, 2006 Oct 20.
Article de Allemand | MEDLINE | ID: mdl-17043982

RÉSUMÉ

BACKGROUND AND OBJECTIVE: Currently liver transplantation (LTx) is the only effective curative therapy of end-stage primary biliary cirrhosis (PBC). Recent data have shown a recurrence rate of up to 32%. However, many studies are based on only a small number of patients with a marginal follow-up below 10 years. It was the aim of this study to analyse survival and complication rates after LTx among 100 patients in a long-term follow-up of up to 17 years. PATIENTS AND METHODS: Between 1989 and 2006 data of 115 patients receiving LTx for PBC at the Charité Campus Virchow were retrospectively analysed. The median age of 89 women (84%) and 17 men (16%) was 54 years (25-67). RESULTS: Actuarial patient survival rate after 10 and 17 years was 88% and 83%. 13 patients (12%) died after a median survival time of 42 months (0.5-136). Two of these patients developed organ dysfunction due to recurrence of PBC. In addition, histological recurrence was found in 17 patients (16%) after a median time of 61 months (36-158). Survival analysis of hospital stay, preoperative Child-Pugh score, rejection episodes, PBC recurrence and retransplantation showed no significant results. CONCLUSION: Long-term follow-up of up to 17 years after liver transplantation for primary biliary cirrhosis showed excellent survival rates. Both the amount and severity of postoperative complications and the preoperative Child-Pugh score did not affect the long-time survival rate significantly.


Sujet(s)
Cirrhose biliaire/mortalité , Cirrhose biliaire/chirurgie , Transplantation hépatique , Complications postopératoires/épidémiologie , Adulte , Sujet âgé , Femelle , Études de suivi , Allemagne/épidémiologie , Rejet du greffon/épidémiologie , Survie du greffon , Humains , Transplantation hépatique/mortalité , Mâle , Adulte d'âge moyen , Complications postopératoires/mortalité , Récidive , Études rétrospectives , Taux de survie , Facteurs temps , Résultat thérapeutique
19.
Nuklearmedizin ; 45(4): 177-84, 2006.
Article de Anglais | MEDLINE | ID: mdl-16964344

RÉSUMÉ

PURPOSE: Before locally ablative treatment of colorectal liver metastases, patients have to be carefully evaluated to decide whether this is the adequate therapy. In this study we determined the value of FDG-PET in comparison to conventional staging procedures. PATIENTS, METHODS: In 68 consecutive patients referred for laser induced thermotherapy (LITT) of liver metastases from colorectal cancer, pretherapeutic staging with conventional imaging (thoracic and abdominal CT, liver MRI, chest X-ray) and FDG-PET was performed. The examinations were analysed separately and blinded. Based on the staging information, therapeutic decisions were made by an interdisciplinary review board according to a standardized algorithm. The results were compared between conventional imaging and FDG-PET, and were validated by clinical follow up data and histopathology, respectively. RESULTS: On FDG-PET 210 lesions were interpreted as tumour manifestations. 48 of these were not seen on conventional imaging (true positive, n = 46). In contrast, 24 lesions were visualized by conventional imaging only (true positive, n = 12). Compared to conventional imaging, discrepant findings on FDG-PET led to treatment modifications in 25 patients (37%); these were correct in 20/25 patients. According to the actual treatment course, the inadequate treatment modifications in the remaining 5 patients were avoided by further diagnostic procedures (i.e. biopsies). CONCLUSION: In the evaluation of patients with known liver metastases from colorectal cancer before LITT, FDG-PET depicts relevant findings subsidiary to conventional imaging and thus is of high value for therapeutic decision making.


Sujet(s)
Tumeurs colorectales/anatomopathologie , Fluorodésoxyglucose F18 , Hyperthermie provoquée , Tumeurs du foie/chirurgie , Tumeurs du foie/thérapie , Humains , Lasers , Tumeurs du foie/imagerie diagnostique , Tumeurs du foie/secondaire , Tomographie par émission de positons , Radiopharmaceutiques , Études rétrospectives , Sensibilité et spécificité , Tomodensitométrie
20.
Endoscopy ; 38(8): 841-4, 2006 Aug.
Article de Anglais | MEDLINE | ID: mdl-17001576

RÉSUMÉ

BACKGROUND AND STUDY AIMS: The use of fibrin glue derived from humans or animals has been reported as an alternative method of mesh fixation, instead of staples, in inguinal hernia repair. However, fibrin sealants involve the potential risks of virus transmission or immunological reactions to foreign proteins. This risk could be avoided by using autologous fibrin derived from the patient. A feasibility study on the use of autologous fibrin was therefore carried out in patients undergoing laparoscopic transabdominal inguinal hernia repair. PATIENTS AND METHODS: In a series of 10 patients undergoing laparoscopic transabdominal inguinal hernia repair, autologous fibrin was produced from 120 ml of the patient's blood during the hernia repair. The process took an average of 20 min. The perioperative and postoperative results were compared with those in a control group of 20 patients in whom conventional fibrin was used. RESULTS: Producing and applying the autologous fibrin was uncomplicated. No differences in the outcome were observed between the two groups. One patient in the conventional fibrin group developed a seroma. None of the patients reported persistent pain. No recurrences were observed after a mean follow-up period of 9 months (range 6 - 12 months) in the conventional fibrin group and 7 months (range 6 - 8 months) in the autologous fibrin group. CONCLUSIONS: This feasibility study suggests that autologous fibrin sealant allowed adequate mesh fixation that did not differ from that in a control group in whom conventional fibrin glue was used. Autologous fibrin may be an interesting alternative for a variety of laparoscopic and endoscopic applications.


Sujet(s)
Colle de fibrine , Hernie inguinale/chirurgie , Laparoscopie , Filet chirurgical , Femelle , Humains , Laparoscopie/méthodes , Mâle , Adulte d'âge moyen
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE